Your shopping cart is currently empty

OR-1896-d3 is the deuterium-labeled form of OR-1896, which is the active, long-lasting metabolite of Levosimendan. It acts as a highly selective phosphodiesterase (PDE III) inhibitor and serves as a potent vasodilator. OR-1896 is capable of opening ATP-sensitive K+ channels and demonstrates Ca2+ sensitizing effects, which help reduce apoptosis in myocardial cells, cardiac remodeling, and myocardial inflammation.
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | OR-1896-d3 is the deuterium-labeled form of OR-1896, which is the active, long-lasting metabolite of Levosimendan. It acts as a highly selective phosphodiesterase (PDE III) inhibitor and serves as a potent vasodilator. OR-1896 is capable of opening ATP-sensitive K+ channels and demonstrates Ca2+ sensitizing effects, which help reduce apoptosis in myocardial cells, cardiac remodeling, and myocardial inflammation. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.